Topical corticosteroids: Proposal for the package labelling to state their potency

Page 1 of 6

Closes 28 Jul 2025

Your details

You are encouraged to fill in this section. The information will help in the analysis of stakeholder comments. Your submission will still be accepted if you do not fill in this section.

1. What is your name?
2. What is your email address?
3. Are you providing feedback:
4. Where are you or your organisation based?
5. Which of the following best describes you in the context of this consultation?